GoHealth, Inc. (GOCO) P/E Ratio History
Deep ValueTrading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2021–2021
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, GoHealth, Inc. (GOCO) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.30 and trailing twelve-month earnings per share of $-17.90.
The current P/E is 100% below its 5-year average of 54.3x. Over the past five years, GOCO's P/E has ranged from a low of 54.3x to a high of 54.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.6x, GOCO trades at a 100% discount to its sector peers. The sector includes 783 companies with P/E ratios ranging from 0.0x to 196.5x.
Relative to the broader market, GOCO trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GOCO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GOCO Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
GOCO P/E vs Peers
Digital insurance marketplaces and brokers peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $174M | 74.3 | - | +107%Best | |
| $10B | 17.7Lowest | 1.24Best | +24% | |
| $8B | 69.5 | - | -4% | |
| $364B | 30.3 | - | -15% | |
| $43B | 36.7 | - | -1% | |
| $125B | 70.7 | - | -62% | |
| $10B | 21.9 | - | -56% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
GOCO Historical P/E Data (2021–2021)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2021 Q3 | - | $75.45 | $1.39 | 54.3x | +0% |
Average P/E for displayed period: 54.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GOCO — Frequently Asked Questions
Quick answers to the most common questions about buying GOCO stock.
What is GOCO's P/E ratio?
GoHealth, Inc. (GOCO) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-17.90. The 5-year average P/E is 54.3x and the historical range spans 54.3x to 54.3x.
Is GOCO stock overvalued or undervalued?
GOCO current P/E: -0.0x. 5-year average P/E: 54.3x. Percentile: 0th.
Is GOCO stock expensive?
GOCO is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 54.3x (0th percentile of historical range).
What is GOCO's historical P/E range?
Over the past 5 years, GOCO's P/E ratio has ranged from 54.3x to 54.3x, with a median of 54.3x and an average of 54.3x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2021–2021.
How does GOCO's P/E compare to the S&P 500?
GOCO current P/E: -0.0x. S&P 500 median P/E: 24.4x.
How does GOCO's valuation compare to Financial Services peers?
GoHealth, Inc. P/E of -0.0x can be benchmarked against Financial Services peers in the comparison table on this page.
What is GOCO's PEG ratio?
GOCO PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of -2956.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is GOCO's earnings yield?
GOCO earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.